Systemic glucocorticosteroids for degenerative back pain: efficacy in radiculopathy and musculoskeletal pain syndrome

Evzikov G.Yu.; Gaydash M.I.

doi:https://doi.org/10.17116/pain20252304154

Close metadata

Recommended articles:

Resolution of the extended meeting of the Presidium and committees of the Russian Association for the Study of Pain (RASP) “The role of central muscle relaxants in the treatment of non-specific low back pain”. Russian Journal of Pain. 2025;(2):91-91

Relationship between oxidative stress patterns and proinflammatory cytokines in patients with polypous rhinosinusitis under the course of therapeutic physical factors. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2025;(2):42-49

Estimation of pro-inflammatory cytokines and C-reactive protein levels in patients with acute demyelination episode. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):118-121

Markers of inflammation and angiogenesis in patients with ischemic stroke after the new coronavirus infection. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):100-103

Tolosa—Hunt syndrome. Russian Annals of Ophthalmology. 2025;(6):114-118

Biopolymer carriers of polydeoxyribonucleotides for correction of impaired healing of thermal burns. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2026;(1):5-11

Artificial tears and immunosuppressive therapy for immune-mediated disorders of the ocular surface. Russian Annals of Ophthalmology. 2026;(2):64-70

Abstract:

Degenerative spinal disease can manifest as musculoskeletal pain and radiculopathy. Annual global incidence of symptomatic degenerative lumbar spine disease is approximately 266 million cases. This pathology is based on intervertebral disc degeneration. Key factors are pro-inflammatory cytokines, activation of metalloproteinases and mechanotransduction via Piezo1 channels. This review analyzes pathogenetic mechanisms of degenerative spinal disorders and evaluates efficacy and safety of systemic glucocorticosteroids in degenerative spinal pain. Despite the ability of glucocorticosteroids to suppress key inflammatory mediators, their clinical efficacy is limited (only transient improvement in radiculopathy, no advantage over NSAID therapy in musculoskeletal pain, and no effect in spinal stenosis). Concurrently, there is a risk of severe complications in high-risk patients (hypertension, diabetes mellitus) even in short-term treatment. Systemic glucocorticosteroids are not recommended for degenerative back pain due to unfavorable benefit / risk profile.

Keywords:

musculoskeletal back pain

compressive radiculopathy

degenerative spinal disorders

intervertebral disk degeneration

proinflammatory cytokines

Piezo channels

glucocorticosteroids

Authors:

Evzikov G.Yu.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0002-6715-6021

Gaydash M.I.

Kozhevnikov Clinic of Nervous Diseases of the Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0009-0002-7400-2570

Received:

16.05.2025

Accepted:

04.09.2025

Close metadata

References:

Zheng Q, Lin R, Wang D, Zheng C, Xu W. Effects of circulating inflammatory proteins on spinal degenerative diseases: Evidence from genetic correlations and Mendelian randomization study. JOR Spine. 2024;7(2):e1346. Published 2024 June 17. https://doi.org/10.1002/jsp2.1346
Ravindra VM, Senglaub SS, Rattani A, Dewan MC, Härtl R, Bisson E, Park KB, Shrime MG. Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume. Global Spine J. 2018 Dec;8(8):784-794. Epub 2018 Apr 24. PMID: 30560029; PMCID: PMC6293435. https://doi.org/10.1177/2192568218770769
Mohd Isa IL, Teoh SL, Mohd Nor NH, Mokhtar SA. Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration. Int J Mol Sci. 2022;24(1):208. Published 2022 Dec 22. https://doi.org/10.3390/ijms24010208
Kim HS, Wu PH, Jang IT. Lumbar Degenerative Disease Part 1: Anatomy and Pathophysiology of Intervertebral Discogenic Pain and Radiofrequency Ablation of Basivertebral and Sinuvertebral Nerve Treatment for Chronic Discogenic Back Pain: A Prospective Case Series and Review of Literature. Int J Mol Sci. 2020;21(4):1483. Published 2020 Feb 21. https://doi.org/10.3390/ijms21041483
Lorio MP, Beall DP, Calodney AK, Lewandrowski KU, Block JE, Mekhail N. Defining the Patient with Lumbar Discogenic Pain: Real-World Implications for Diagnosis and Effective Clinical Management. J Pers Med. 2023;13(5):821. Published 2023 May 12. https://doi.org/10.3390/jpm13050821
Scarcia L, Pileggi M, Camilli A, Romi A, Bartolo A, Giubbolini F, Valente I, Garignano G, D’Argento F, Pedicelli A, Alexandre AM. Degenerative Disc Disease of the Spine: From Anatomy to Pathophysiology and Radiological Appearance, with Morphological and Functional Considerations. J Pers Med. 2022 Nov 01;12(11):1810. PMID: 36579533; PMCID: PMC9698646. https://doi.org/10.3390/jpm12111810
Shnayder NA, Ashhotov AV, Trefilova VV, Novitsky MA, Medvedev GV, Petrova MM, Narodova EA, Kaskaeva DS, Chumakova GA, Garganeeva NP, Lareva NV, Al-Zamil M, Asadullin AR, Nasyrova RF. High-Tech Methods of Cytokine Imbalance Correction in Intervertebral Disc Degeneration. Int J Mol Sci. 2023 Aug 28;24(17):13333. PMID: 37686139; PMCID: PMC10487844. https://doi.org/10.3390/ijms241713333
Wang X, Wang Q, Li G, Xu H, Liu B, Yuan B, Zhou Y, Li Y. Identifying the protective effects of miR-874-3p/ATF3 axis in intervertebral disc degeneration by single-cell RNA sequencing and validation. J Cell Mol Med. 2024 June; 28(12):e18492. PMID: 38890795; PMCID: PMC11187931. https://doi.org/10.1111/jcmm.18492
Shnayder NA, Ashhotov AV, Trefilova VV, Nurgaliev ZA, Novitsky MA, Vaiman EE, Petrova MM, Nasyrova RF. Cytokine Imbalance as a Biomarker of Intervertebral Disk Degeneration. Int J Mol Sci. 2023 Jan 25;24(3):2360. PMID: 36768679; PMCID: PMC9917299. https://doi.org/10.3390/ijms24032360
Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44-56. https://doi.org/10.1038/nrrheum.2013.160
Byvaltsev VA, Belykh EG, Stepanov IA, Giers M, Preul MC. Cytokine’s Mechanisms of intervertebral disc degeneration. Sibirskij meditsinskij zhurnal (Irkutsk). 2015;137(6):5-11. (In Russ.).
Lyu FJ, Cui H, Pan H, Mc Cheung K, Cao X, Iatridis JC, Zheng Z. Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions. Bone Res. 2021 Jan 29;9(1):7. PMID: 33514693; PMCID: PMC7846842. https://doi.org/10.1038/s41413-020-00125-x
Zhao C-Q, Zhang Y-H, Jiang S-D, Li H, Jiang L-S, Dai L-Y. ADAMTS-5 and intervertebral disc degeneration: the results of tissue immunohistochemistry and in vitro cell culture. J Orthop Res. 2011 May;29(5):718-725. Epub 2010 Nov 15. PMID: 21437951. https://doi.org/10.1002/jor.21285
Wang SL, Yu YL, Tang CL, Lv FZ. Effects of TGF-β1 and IL-1β on expression of ADAMTS enzymes and TIMP-3 in human intervertebral disc degeneration. Exp Ther Med. 2013 Dec;6(6):1522-1526. Epub 2013 Oct 15. PMID: 24250727; PMCID: PMC3829724. https://doi.org/10.3892/etm.2013.1348
Sun Z, Yin Z, Liu C, Liang H, Jiang M, Tian J. IL-1β promotes ADAMTS enzyme-mediated aggrecan degradation through NF-κB in human intervertebral disc. J Orthop Surg Res. 2015 Oct 06;10:159. PMID: 26438479; PMCID: PMC4594913. https://doi.org/10.1186/s13018-015-0296-3
Li C, Li D, Yao X, Sun S, Ren B, Han Y. Expression of lipid metabolism and cartilage degeneration-related factors in lumbar vertebral endplate Modic changes. Jt Dis Relat Surg. 2025 Jan 02;36(1):39-46. Epub 2024 Dec 18. PMID: 39719900; PMCID: PMC11734858. https://doi.org/10.52312/jdrs.2025.1870
Tuncer C, Eminoğlu EM, Yağlı ÖE, et al. The Relationship Between ADAMTS-4 and ADAMTS-5 Enzyme Levels in Patients With Degenerative Disc Disease: A Prospective Biochemical Study. JOR Spine. 2025 Mar; 8(1):e70037. Published 2025 Jan 08. https://doi.org/10.1002/jsp2.70037
Chan SC, Ferguson SJ, Gantenbein-Ritter B. The effects of dynamic loading on the intervertebral disc [published correction appears in Eur Spine J. 2011 Nov;20(11):1813]. Eur Spine J. 2011;20(11):1796-1812. https://doi.org/10.1007/s00586-011-1827-1
Zhang G-Z, Liu M-Q, Chen H-W, Wu Z-L, Gao Y-C, Ma Z-J, He X-G, Kang X-W. NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif. 2021 Jul;54(7):e13057. Epub 2021 May 24. PMID: 34028920; PMCID: PMC8249791. https://doi.org/10.1111/cpr.13057
Lei L, Wen Z, Cao M, Zhang H, Ling SK, Fu BS, Qin L, Xu J, Yung PS. The emerging role of Piezo1 in the musculoskeletal system and disease. Theranostics. 2024 June 24;14(10):3963-3983. PMID: 38994033; PMCID: PMC11234281. https://doi.org/10.7150/thno.96959
Zhang K, Xue C, Lu N, Ren P, Peng H, Wang Y, Wang Y. Mechanical loading mediates human nucleus pulposus cell viability and extracellular matrix metabolism by activating of NF-κB. Exp Ther Med. 2019 Sept;18(3):1587-1594. Epub 2019 July 08. PMID: 31410113; PMCID: PMC6676187. https://doi.org/10.3892/etm.2019.7744
Zhang S, Wang P, Hu B, Lv X, Liu W, Chen S, Shao Z. Inhibiting Heat Shock Protein 90 Attenuates Nucleus Pulposus Fibrosis and Pathologic Angiogenesis Induced by Macrophages via Down-Regulating Cell Migration-Inducing Protein. Am J Pathol. 2023 July;193(7):960-976. Epub 2023 Apr 22. PMID: 37088454. https://doi.org/10.1016/j.ajpath.2023.03.014
Byvaltsev VA, Stepanov IA, Bardonova LA, Belykh EG. Intervertebral Disc Degeneration And Possibilities of Tissue Engineering: Literature Review. Khirurgiya pozvonochnika = Russian Journal of Spine Surgery. 2017;14(1):60-67. (In Russ.). https://doi.org/10.14531/ss2017.1.60-67
Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK, Le Maitre CL. Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther. 2014 Aug 20;16(5):416. PMID: 25209447; PMCID: PMC4177417. https://doi.org/10.1186/s13075-014-0416-1
Strehl C, Ehlers L, Gaber T, Buttgereit F. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System. Front Immunol. 2019;10:1744. Published 2019 July 24. https://doi.org/10.3389/fimmu.2019.01744
Todosenko NM, Koroleva YuA, Khaziakhmatova OG, Yurova KA, Litvinova LS. Genomic and non-genomic effects of glucocorticoids. Genes & Cells. 2017;12(1):27-33. (In Russ.).
Yarushkina NI, Filaretova LP. Effect of Glucocorticoids on Pain Sensitivity: Involvement of Glucocorticoid and Mineralocorticoid Receptors. Uspekhi fiziologicheskikh nauk. 2022;53(4):40-49. (In Russ.). https://doi.org/10.31857/S0301179822040075
Shnayder NA, Ashkhotov AV, Trefilova VV, Nurgaliev ZA, Novitsky MA, Petrova MM, Narodova EA, Al-Zamil M, Chumakova GA, Garganeeva NP, Nasyrova RF. Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment. Int J Mol Sci. 2023 Apr 22;24(9):7692. PMID: 37175399; PMCID: PMC10178334. https://doi.org/10.3390/ijms24097692
Suleymanova AM, Kulichenko TV. safety of application of short courses of glucocorticosteroids: literature review. Farmateka. 2017;11(344):6-13. (In Russ.).
Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017 Apr 12;357:j1415. PMID: 28404617; PMCID: PMC6284230. https://doi.org/10.1136/bmj.j1415
Yao T-C, Huang Y-W, Chang S-M, Tsai S-Y, Wu AC, Tsai H-J. Association Between Oral Corticosteroid Bursts and Severe Adverse Events : A Nationwide Population-Based Cohort Study. Ann Intern Med. 2020;173(5):325-330. https://doi.org/10.7326/M20-0432
Holve RL, Barkan H. Oral steroids in initial treatment of acute sciatica. J Am Board Fam Med. 2008;21(5):469-474. https://doi.org/10.3122/jabfm.2008.05.070220
Goldberg H, Firtch W, Tyburski M, Pressman A, Ackerson L, Hamilton L, Smith W, Carver R, Maratukulam A, Won LA, Carragee E, Avins AL. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. JAMA. 2015 May 19;313(19):1915-1923. PMID: 25988461; PMCID: PMC5875432. https://doi.org/10.1001/jama.2015.4468
Gastaldi R, Durand M, Roustit M, Zulian M, Monteiro I, Juvin R, Gaudin P, Baillet A. Short-term Efficiency and Tolerance of Ketoprofen and Methylprednisolone in Acute Sciatica: A Randomized Trial. Pain Med. 2019 July 01;20(7):1294-1299. PMID: 30576555. https://doi.org/10.1093/pm/pny252
Rodrigues LC, Natour J. A double-blind, randomized controlled, prospective trial assessing the effectiveness of oral corticoids in the treatment of symptomatic lumbar canal stenosis. J Negat Results Biomed. 2014;13:13. Published 2014 Aug 07. https://doi.org/10.1186/1477-5751-13-13
Ghasemi M, Masaeli A, Rezvani M, Shaygannejad V, Golabchi K, Norouzi R. Oral prednisolone in the treatment of cervical radiculopathy: A randomized placebo controlled trial. J Res Med Sci. 2013;18(Suppl 1):S43-S46.
Shahien R, Beiruti Wiegler K, Dekel L, Sharabi-Nov A, Abu Saleh S. Retrospective study assessing the efficacy of i.v. dexamethasone, SNRB, and nonsteroidal treatment for radiculopathy. Medicine (Baltimore). 2022;101(28): e29272. Published 2022 July 15. https://doi.org/10.1097/MD.0000000000029272
Hershkovich O, Mor Y, Lotan R. Intravenous Corticosteroid Therapy for Acute Lumbar Radicular Pain. J Clin Med. 2022;11(17):5127. Published 2022 Aug 31. https://doi.org/10.3390/jcm11175127
Kovarsky D, Shani A, Rod A, Ciubotaru D, Rahamimov N. Effectiveness of intra-venous steroids for preventing surgery for lumbo-sacral radiculopathy secondary to intervertebral disc herniation: a retrospective study of 213 patients. Sci Rep. 2022;12(1):6681. Published 2022 Apr 23. https://doi.org/10.1038/s41598-022-10659-1
Gall N, Ghaffari C, Koduri J, Dove C, Levin J. Systemic steroids for cervical radicular pain: A systematic review. Interv Pain Med. 2023;2(4):100280. Published 2023 Oct 01. https://doi.org/10.1016/j.inpm.2023.100280
Chou R, Pinto RZ, Fu R, Lowe RA, Henschke N, McAuley JH, Dana T. Systemic corticosteroids for radicular and non-radicular low back pain. Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD012450. PMID: 36269125; PMCID: PMC9585990. https://doi.org/10.1002/14651858.CD012450.pub2